Therefore, FCM-NPs have the antigen presentation ability of DCs, increases the expression levels of co-stimulatory molecules such as CD80 and CD86, and stimulates immature T lymphocytes to produce a large number of tumor-specific cytotoxic CD8+T lymphocytes. Here, CD8A is linked to neoplasm.